Neuronetics Inc (STIM) Stock Analysis

Verdict: WATCH (do not buy)

Greenbrook acquisition scales revenue and narrows losses, but an $86.5M debt burden and limited cash runway demand strict execution.

Investment score: 54/100

Analysis as of

Is Neuronetics Inc stock worth reviewing? AI model thesis

The model rates STIM as a HOLD. Strong revenue growth post-Greenbrook acquisition and narrowing operating losses are tempered by $86.5M in debt and tight liquidity ($19.2M cash), requiring operational cash flow sustainability before a BUY rating is warranted.

7-factor investment score

Neuronetics Inc opportunities and risks

What speaks for STIM

What speaks against STIM

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
STIMn/a1.3xn/a49.1%-19.6%-5.1%
PDEX17.4x3.0x12.3x31.4%17.6%2.9%
ELMD20.3x3.1x13.7x78.5%15.3%4.0%
USBCn/a0.0xn/a0.0%0.0%-8053.5%
Peer median17.4x3.0x12.3x31.4%15.3%2.9%

Frequently asked questions about Neuronetics Inc (STIM)

Is STIM stock a good investment?

The cached TradeMates AI model rates Neuronetics Inc as WATCH (do not buy) with an investment score of 54/100. The model rates STIM as a HOLD. Strong revenue growth post-Greenbrook acquisition and narrowing operating losses are tempered by $86.5M in debt and tight liquidity ($19.2M cash), requiring operational cash flow sustainability before a BUY rating is warranted. This is algorithmic model output, not personal investment advice.

Is STIM stock a buy?

The TradeMates model verdict for STIM is WATCH (do not buy) with an investment score of 54/100. Treat this as a model signal to review, not a personal buy recommendation.